Bottom line
RYWCX vs XSMO: the short answer
RYWCX (S&P SmallCap 600 Pure Growth Fund) and XSMO (Invesco S&P SmallCap Momentum ETF) are both mutual funds.
XSMO is cheaper at 0.35% vs 2.28% — a difference of $193 a year per $10,000 invested.
Over five years, XSMO returned +9.6% a year vs +2.2% for RYWCX.
Updated Nov 19, 2026
RYWCX vs XSMO side by side
| RYWCX | XSMO | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Guggenheim | Invesco |
| Category | Small-Cap | Small-Cap |
| Expense ratio | 2.28% | 0.35% |
| Annual cost per $10k | $228 | $35 |
| 10-yr cost on $10k (prospectus) | $2,662 | $444 |
| Max front load | 0% | None |
| 12b-1 fee | 1% | — |
| 1-yr return | +6.8% | +9.8% |
| 5-yr return (annualized) | +2.2% | +9.6% |
| 10-yr return (annualized) | +5.8% | +12.3% |
| Best quarter | +31.1% | +23.7% |
| Worst quarter | −35.4% | −25.2% |
| Net assets (fund) | $60.7M | $3.0B |
| Number of holdings | 129 | 110 |
| Portfolio turnover | 1,133% | 121% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | RYWCX | XSMO | Difference |
|---|---|---|---|
| 2025 | +7.8% | +9.8% | −2.1% |
| 2024 | +7.4% | +17.6% | −10.2% |
| 2023 | +17.0% | +21.4% | −4.4% |
| 2022 | −30.3% | −15.5% | −14.9% |
| 2021 | +18.0% | +19.3% | −1.3% |
| 2020 | +15.2% | +21.8% | −6.6% |
| 2019 | +11.6% | +28.3% | −16.8% |
| 2018 | −9.6% | −2.9% | −6.7% |
| 2017 | +15.3% | +23.4% | −8.1% |
| 2016 | +17.5% | +7.2% | +10.3% |
Source: Fund prospectus bar charts
Holdings overlap
9 of RYWCX's top 25 holdings also appear in XSMO's top 25.
| Holding | RYWCX | XSMO |
|---|---|---|
| Acm Research Inc | 3.80% | 1.78% |
| Powell Industries Inc | 2.05% | 1.76% |
| Stonex Group Inc | 1.66% | 2.17% |
| Protagonist Therapeutics Inc | 1.59% | 2.57% |
| Myr Group Inc | 1.48% | 1.59% |
| Enova International Inc | 1.47% | 1.52% |
| Ptc Therapeutics Inc | 1.41% | 1.43% |
| Viasat Inc | 1.37% | 4.59% |
| Ligand Pharmaceuticals Inc | 1.23% | 1.88% |
Source: SEC Form N-PORT
RYWCX top 10
- Acm Research Inc — 3.80%
- Powell Industries Inc — 2.05%
- Argan Inc — 2.04%
- Dave Inc — 1.85%
- Stonex Group Inc — 1.66%
- Protagonist Therapeutics Inc — 1.59%
- Sphere Entertainment Company — 1.56%
- Clear Secure Inc — 1.54%
- Alignment Healthcare Inc — 1.53%
- Liquidia Corp — 1.51%
XSMO top 10
- Invesco Private Prime Fund — 11.81%
- Viasat, Inc. — 4.59%
- Invesco Private Government Fund — 4.51%
- ESCO Technologies Inc. — 2.97%
- Protagonist Therapeutics, Inc. — 2.57%
- Indivior Pharmaceuticals, Inc. — 2.20%
- Mercury Systems, Inc. — 2.17%
- StoneX Group Inc. — 2.17%
- FormFactor, Inc. — 1.98%
- Ligand Pharmaceuticals Inc. — 1.88%
FAQ
What is the difference between RYWCX and XSMO?
Which is cheaper, RYWCX or XSMO?
Should I own both RYWCX and XSMO?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.